D-0146-2021 Class II Terminated

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0146-2021 was initiated by Zydus Pharmaceuticals (USA) Inc on Dec 3, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Dec 20, 2022). Affected quantity: 22,848 cartons.

Recall details

Product Type
Drugs
Report Date
Dec 23, 2020
Initiation Date
Dec 3, 2020
Termination Date
Dec 20, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,848 cartons

Product description

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-772-77

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

M900412 December 2020 M904772 February 2021 M915745 October 2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0146-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0146-2021. Report a data issue: hello@regdatalab.com.